Literature DB >> 15237969

Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo.

Katsuhiko Takano1, Keiko Nakaima, Makoto Nitta, Futoshi Shibata, Hideo Nakagawa.   

Abstract

The effect of (-)-epigallocatechin 3-gallate (EGCG), a major polyphenol of green tea, on neutrophil migration has been studied using multiwell-type Boyden chambers in vitro and a fluorescein isothiocyanate-labeled ovalbumin (FITC-OVA)-induced rat allergic inflammation model in vivo. EGCG inhibited rat neutrophil chemotaxis toward cytokine-induced neutrophil chemoattractant-1 (CINC-1) in a concentration-dependent manner. In addition, CINC-1-induced neutrophil chemotaxis was suppressed by the pretreatment of rat neutrophils with EGCG at the concentration over 15 microg/mL. EGCG caused concentration-dependent suppression of the transient increase in CINC-1-induced intracellular free calcium level in both rat neutrophils and rat CXC chemokine receptor 2 (CXCR2)-transfected HEK 293 cells. EGCG inhibited CINC-1 production by IL-1beta-stimulated rat fibroblasts (NRK-49F cells) and lipopolysaccharide-stimulated rat macrophages at the concentration over 50 microg/mL, a comparatively high concentration. Oral administration of EGCG (1.0 mg or 1.5 mg/rat) at 1 h before the challenge with FITC-OVA suppressed neutrophil infiltration into the air pouch (inflammatory site) in the air-pouch type FITC-OVA-induced allergic inflammation in rats. Chemokine levels in the pouch fluids, however, were not influenced by EGCG administration. The results suggest that EGCG suppressed neutrophil infiltration by a direct action on neutrophils, but not by indirect actions, including the suppression of chemokine production at the inflammatory site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237969     DOI: 10.1021/jf0355194

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  25 in total

1.  EGCG induces G-CSF expression and neutrophilia in experimental sepsis.

Authors:  Wei Li; Andrew H Wu; Shu Zhu; Jianhua Li; Rong Wu; John D'Angelo; Haichao Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.

Authors:  Jingjing Zhu; Oumei Wang; Lingfei Ruan; Xinwei Hou; Youhong Cui; Ji Ming Wang; Yingying Le
Journal:  Int Immunopharmacol       Date:  2009-05-06       Impact factor: 4.932

Review 3.  The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease.

Authors:  Hui Bao; Ai Peng
Journal:  J Transl Int Med       Date:  2016-09-23

4.  Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.

Authors:  Junpeng Wang; Zhihong Ren; Yanmei Xu; Sheng Xiao; Simin N Meydani; Dayong Wu
Journal:  Am J Pathol       Date:  2011-11-03       Impact factor: 4.307

5.  Tea polyphenols protect bovine mammary epithelial cells from hydrogen peroxide-induced oxidative damage in vitro.

Authors:  Yanfen Ma; Lei Zhao; Min Gao; Juan J Loor
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

6.  The effect of epigallocatechin gallate on lipopolysaccharide-induced acute lung injury in a murine model.

Authors:  Hong-Beom Bae; Mei Li; Jong-Phil Kim; Seok-Jai Kim; Cheol-Won Jeong; Hyung-Gon Lee; Woong-Mo Kim; Hyung-Seok Kim; Sang-Hyun Kwak
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

Review 7.  Green tea catechins and cardiovascular health: an update.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

8.  Epigallocatechin gallate inhibits endothelial exocytosis.

Authors:  Munekazu Yamakuchi; Clare Bao; Marcella Ferlito; Charles J Lowenstein
Journal:  Biol Chem       Date:  2008-07       Impact factor: 3.915

9.  Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.

Authors:  Christina L Nance; Edward B Siwak; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

10.  Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.

Authors:  Shulin Qin; Cynthia R Klamar; Beth A Fallert Junecko; Jodi Craigo; Deborah H Fuller; Todd A Reinhart
Journal:  Cytokine       Date:  2013-01-27       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.